A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With Hypertension
ConditionHypertension
Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age18-75
SponsorCRISPR Therapeutics AG